Forecasts on the Impacts of Tariff Policy on U.S. Healthcare

Forecasts on the Impacts of Tariff Policy on U.S. Healthcare

Due to their geopolitical and economic consequences, tariff policies can have downstream effects on critical sectors like healthcare. As the U.S. imposes or adjusts tariffs on medical supplies, pharmaceuticals, and raw materials, healthcare providers find themselves facing unexpected financial and operational consequences. Forecasting the impact of these trade policies is challenging but essential.

Many critical healthcare items, ranging from surgical gloves and syringes to imaging equipment and generic medications, are either imported directly or rely on imported components. When tariffs are applied to countries like China or India, which supply a large share of medical consumables or active pharmaceutical ingredients, U.S. suppliers often pass the added costs onto consumers. As a result, hospitals and clinics experience price increases in routine products that often have little room for substitution 1,2.

These increases are not, however, always immediate, since existing stockpiles can often buffer the initial shock. Within a few months, though, providers typically begin to see procurement costs climb, particularly for high-volume, low-margin items. Forecast data appear to suggest that if tariffs remain or expand, operational budgets could see a roughly 10% rise in baseline supply spending across health systems within a year 3–5.

In addition to raising prices, tariffs also disrupt logistics for the U.S. healthcare system. Higher import costs tend to push suppliers to seek alternative sources, sometimes from countries with less regulatory oversight or slower delivery pipelines. This shift can lead to unpredictable backorders, stockouts, or quality variability—in the last few years, even minor trade disruptions have tended to cause cascading shortages of critical drugs and devices.

Healthcare systems already operating with thin margins are especially vulnerable. Indeed, smaller hospitals, rural providers, and independent clinics lack the buying power to absorb cost spikes or pivot supply chains rapidly. Larger institutions, however, may be able to negotiate bulk deals or shift to domestic alternatives, but they still face long-term pressures as pricing structures across the industry adjust upward 6–8.

To manage tariff-related volatility, some healthcare systems are increasingly relying on predictive analytics and diversified sourcing. By tracking geopolitical developments, raw material prices, and customs trends, some medical supplies procurement teams are building short-term forecasts to guide purchasing strategy. Others may be forming purchasing alliances or investing in domestic manufacturing partnerships to limit exposure to tariff-sensitive imports.

At the federal level, some policymakers advocate for strategic exemptions or medical-specific tariff relief to shield healthcare from trade disputes. That said, however, such protections are temporary and often reactive. The longer-term trend suggests that global supply chain risks, including those tied to tariffs, will remain a core concern for healthcare logistics 8–10.

The downstream effects of tariffs on U.S. healthcare are far-reaching: rising costs, supply uncertainty, and pressure on margins are likely to persist if current trends continue. For providers and policymakers alike, anticipating these impacts is no longer optional, and a more resilient, adaptable supply strategy is needed to weather the ongoing turbulence in global trade and continue to protect patient care.

References

1. Fact Sheet: Impact of Tariffs on Health Care Equipment | AHA. https://www.aha.org/2024-07-01-fact-sheet-impact-tariffs-health-care-equipment.

2. Economics, C. of B. and & Watson, K. Overview of the U.S Healthcare Supply Chain. College of Business and Economics https://www.boisestate.edu/cobe/blog/2025/04/overview-of-the-u-s-healthcare-supply-chain/ (2025).

3. How Tariffs Could Impact Managed Care and the US Economy. https://www.ajmc.com/view/how-tariffs-could-impact-managed-care-and-the-us-economy.

4.Tovar, C. N., Jennifer F. Revis, Evan Rush, Magda. The Impact of Tariffs on the Life Sciences Industry. Healthcare & Life Sciences Blog https://healthcarelifesciences.bakermckenzie.com/2025/03/13/the-impact-of-tariffs-on-the-life-sciences-industry/ (2025).

5. How Tariffs Could Impact Managed Care and the US Economy. AJMC https://www.ajmc.com/view/how-tariffs-could-impact-managed-care-and-the-us-economy (2025).

6. The Impact of Tariffs on the U.S. Healthcare System: Economic and Policy Considerations. CTeL.org https://www.ctel.org/breakingnews/the-impact-of-tariffs-on-the-us-healthcare-system-economic-and-policy-considerations.

7. The Ripple Effect of Tariffs on Healthcare Supply Chains. https://www.definitivehc.com/blog/how-tariffs-affect-healthcare-supply.

8. Health care sector braces for supply chain uncertainty with changing tariff policies. AAMC https://www.aamc.org/news/health-care-sector-braces-supply-chain-uncertainty-changing-tariff-policies.

9. Kingsley Anyaso & Victor Okoye. The Impact of Big Data and Predictive Analytics on U.S. Healthcare Delivery: Opportunities, Challenges, and Future Directions. World J. Adv. Res. Rev. 24, 2275–7787 (2024).    DOI: 10.30574/wjarr.2024.24.1.3266

10. Sumrit, D. An investigation of the impact of organizational big data analytics capabilities on healthcare supply chain resiliency. Healthcare Analytics. 7, 100393. DOI: 10.1016/j.health.2025.100393